Serotonin syndrome masquerading as disease flare in lupus nephritis with end ‐stage renal disease
ConclusionSerotonin syndrome should be considered in patients on multiple serotonergic agents on the background of end ‐stage renal disease. Prompt recognition and distinction from lupus activity can significantly impact management decisions.
Source: International Journal of Rheumatic Diseases - Category: Rheumatology Authors: Rodeo V. Navarroza,
Leonid D. Zamora,
Sandra V. Navarra Tags: APLAR GRAND ROUND CASE Source Type: research
More News: Anemia | Brain | Dialysis | Hemodialysis | Hydrocortisone | Hypertension | Insomnia | Linezolid | Lupus | Men | Nephritis | Neurology | Pain | Pain Management | Rhabdomyolysis | Rheumatology | Thrombocytopenia | Tramadol | Tuberculosis | Zyvox